OpGen, Inc. (OPGN)
OTCMKTS · Delayed Price · Currency is USD
15.50
-2.59 (-14.32%)
At close: Jan 20, 2026
OpGen Market Cap
OpGen has a market cap or net worth of $157.32 million as of January 20, 2026. Its market cap has increased by 841.39% in one year.
Market Cap
157.32M
Enterprise Value
158.80M
Revenue
9.00M
Ranking
n/a
PE Ratio
41.22
Stock Price
$15.50
Market Cap Chart
Since May 5, 2015, OpGen's market cap has increased from 51.90M to 157.32M, an increase of 203.14%. That is a compound annual growth rate of 10.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 183.60M | 13.77% |
| Dec 31, 2025 | 161.38M | 2,593.85% |
| Dec 31, 2024 | 5.99M | 42.44% |
| Dec 29, 2023 | 4.21M | -44.45% |
| Dec 30, 2022 | 7.57M | -80.56% |
| Dec 31, 2021 | 38.95M | -15.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |